Trials / Completed
CompletedNCT00486200
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 695 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP2151 | Oral administration. |
| DRUG | valacyclovir | Oral administration of active comparator. |
| DRUG | Placebo | Oral administration of placebo. |
Timeline
- Start date
- 2007-06-21
- Primary completion
- 2008-08-12
- Completion
- 2008-08-12
- First posted
- 2007-06-14
- Last updated
- 2017-12-07
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00486200. Inclusion in this directory is not an endorsement.